Zepatier
DAA Linked to High Response in Vets With HCV
U.S. veterans are three times more likely to have chronic HCV compared with the general U.S. population. Many also ...
MAY 3, 2017
The FDA Approves Zepatier To Treat HCV
Zepatier achieves SVR12 in a broad range of HCV patients, including those with compensated cirrhosis, renal ...
JANUARY 29, 2016
Load more